Your browser doesn't support javascript.
Machine learning to assist clinical decision-making during the COVID-19 pandemic
Bioelectronic Medicine ; 6(1):14-14, 2020.
Artículo | WHO COVID | ID: covidwho-637250
The number of cases from the coronavirus disease 2019 (COVID-19) global pandemic has overwhelmed existing medical facilities and forced clinicians, patients, and families to make pivotal decisions with limited time and information While machine learning (ML) methods have been previously used to augment clinical decisions, there is now a demand for “Emergency ML ” Throughout the patient care pathway, there are opportunities for ML-supported decisions based on collected vitals, laboratory results, medication orders, and comorbidities With rapidly growing datasets, there also remain important considerations when developing and validating ML models This perspective highlights the utility of evidence-based prediction tools in a number of clinical settings, and how similar models can be deployed during the COVID-19 pandemic to guide hospital frontlines and healthcare administrators to make informed decisions about patient care and managing hospital volume





Texto completo: Disponible Colección: Bases de datos de organismos internacionales Base de datos: WHO COVID Tipo del documento: Artículo Revista: Bioelectronic Medicine Aspecto clínico: Predicción Año: 2020